Chronic Lymphocytic Leukemia — An Interview with Prof Constantine Tam on Key Presentations from the 2025 ASH Annual Meeting
Oncology Today with Dr Neil Love
00:00
CLL17: time-limited versus continuous evidence
Tam interprets CLL17 showing similar early outcomes but possible later PFS differences between continuous BTKi and time-limited venetoclax regimens.
Play episode from 14:37
Transcript
